Longaeva Partners »

Beam Therapeutics shares owned by Longaeva Partners

Quarter-by-quarter ownership of Beam Therapeutics (BEAM) shares owned by Longaeva Partners from 13F filings

Historical chart of Longaeva Partners investment in Beam Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Beam Therapeutics held by Longaeva Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Beam Therapeutics by Longaeva Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $370k 16k 23.83

More positions owned by Longaeva Partners

Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Boston Scientific Corporation Call Option (BSX)
Bank of America Corporation (BAC)
NVIDIA Corporation Call Option (NVDA)
PNC Financial Services (PNC)
Key (KEY)
Goldman Sachs (GS)
Morgan Stanley Com New (MS)
Minimed Group
Citizens Financial (CFG)
Evercore Class A (EVR)
Mastercard Incorporated Cl A (MA)
Msci (MSCI)
S&p Global (SPGI)
Us Bancorp Com New (USB)

View all positions for Longaeva Partners

Top funds holding Beam Therapeutics

ARK Investment Management
FMR
Farallon Capital Management
Vanguard Group
BlackRock
State Street Corporation
Vanguard Portfolio Management
Arch Venture Corp
Vanguard Capital Management
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Kynam Capital Management
Geode Capital Management
Dimensional Fund Advisors
Ubs Global Asset Management Americas

View all funds holding Beam Therapeutics